AlphaCentric Advisors’s Arcutis Biotherapeutics ARQT Stock Holding History

Quarter	Market Value	Status	Shares	Shares Change %	Trade Value	Portfolio Weight	Portfolio Position
2023 Q4	–	Sell	-165,000	Closed	-$876K	–	230
2023 Q3	$876K	Sell	165,000 -127,500	-44%	-$677K	0.5%	71
2023 Q2	$2.79M	Buy	292,500 +102,500	+54%	+$977K	1.55%	11
2023 Q1	$2.09M	Buy	190,000 +111,500	+142%	+$1.23M	1.44%	15
2022 Q4	$1.16M	Buy	+78,500	New	+$1.16M	1.15%	25
2021 Q4	$1.09M	Buy	52,500 +17,000	+48%	+$353K	0.32%	29
2021 Q3	$848K	Buy	35,500 +22,000	+163%	+$526K	0.22%	40
2021 Q2	$368K	Buy	13,500 +1,500	+13%	+$40.9K	0.1%	79
2021 Q1	$347K	Buy	+12,000	New	+$347K	0.12%	70